Clinical Trial Update: Randomized Double-blind Trial to Study the Benefit of Colchicine in Patients With Acutely Decompensated Heart Failure [Phase 3]

View source ↗

Summary

A Phase 3 randomized double-blind trial evaluated the benefit of colchicine in patients with acutely decompensated heart failure; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | Conditions: HEART FAILURE | Phase 3 | Status: COMPLETED